Hyderabad, India-based Aurobindo Pharma submitted an initial $1.6 billion bid to purchase Novartis' dermatology generics drug business, which includes dermatology brands plus the company's production facilities and other infrastructure.
Aurobindo bids to purchase Novartis' generics drug dermatology business
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.